High seroprevalence but short‐lived immune response to SARS‐CoV‐2 infection in Paris-Reference-Cited by-同舟云学术

High seroprevalence but short‐lived immune response to SARS‐CoV‐2 infection in Paris

Published:2020-12-23 Issue:1 Volume:51 Page:180-190
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Anna François¹,Goyard Sophie²³,Lalanne Ana Ines⁴⁵,Nevo Fabien¹,Gransagne Marion⁶,Souque Philippe⁷,Louis Delphine⁴⁵,Gillon Véronique⁸,Turbiez Isabelle⁸,Bidard François‐Clément⁵⁹¹⁰,Gobillion Aline¹¹,Savignoni Alexia¹¹,Guillot‐Delost Maude⁵¹²,Dejardin François¹³,Dufour Evelyne¹³,Petres Stéphane¹³,Richard‐Le Goff Odile¹⁴,Choucha Zaineb⁶,Helynck Olivier¹⁵,Janin Yves L.¹⁵,Escriou Nicolas⁶,Charneau Pierre¹⁷,Perez Franck¹⁶,Rose Thierry²³^ORCID,Lantz Olivier⁴⁵¹²^ORCID

Affiliation:

1. Theravectys Paris France

2. Unit of Lymphocyte Cell Biology Immunology Department, Institut Pasteur Paris France

3. INSERM 1221 Institut Pasteur Paris France

4. Laboratoire d'Immunologie Clinique Institut Curie Paris France

5. Centre d'Investigation Clinique en Biothérapie (CIC‐BT1428) Institut Curie Paris France

6. Innovation Laboratory: Vaccines Institut Pasteur Paris France

7. Unit of Molecular Virology and Vaccinology Virology Department, Institut Pasteur Paris France

8. Direction of the Clinical Research Institut Curie Paris France

9. Medical Oncology Department Institut Curie Paris France

10. UVSQ Paris‐Saclay University Saint‐Cloud France

11. Biometry Institut Curie Paris France

12. INSERM U932, PSL University Institut Curie Paris France

13. Production and Purification of Recombinant Proteins Technological Platform, Institut Pasteur Paris France

14. Unit of Antibody in Therapy and Pathology Institut Pasteur Paris France

15. Unit of Chemistry and Biocatalysis Institut Pasteur, CNRS UMR 3523 Paris France

16. Cell Biology and Cancer Unit, Institut Curie, CNRS UMR 144 PSL Research University Paris France

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/eji.202049058

Reference41 articles.

1. Clinical Characteristics of Coronavirus Disease 2019 in China

2. A new coronavirus associated with human respiratory disease in China

3. A Novel Coronavirus from Patients with Pneumonia in China, 2019

4. Clinical and virological data of the first cases of COVID-19 in Europe: a case series

5. Virological assessment of hospitalized patients with COVID-2019

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MBPCA-OS: an exploratory multiblock method for variables of different measurement levels. Application to study the immune response to SARS-CoV-2 infection and vaccination;The International Journal of Biostatistics;2023-12-13

2. Application of Machine Learning Prediction of Individual SARS-CoV-2 Vaccination and Infection Status to the French Serosurveillance Survey From March 2020 to 2022: Cross-Sectional Study;JMIR Public Health and Surveillance;2023-11-28

3. Systematic review of seroprevalence of SARS-CoV-2 antibodies and appraisal of evidence, prior to the widespread introduction of vaccine programmes in the WHO European Region, January–December 2020;BMJ Open;2023-11

4. One-Year Follow-Up of Seroprevalence of SARS-CoV-2 Infection and Anxiety among Health Workers of a French Cancer Center: The PRO-SERO-COV Study;International Journal of Environmental Research and Public Health;2023-05-25

5. Antigen-Specific Antibody Signature Is Associated with COVID-19 Outcome;Viruses;2023-04-20